BrainStorm Cell Therapeutics has reported that a patient diagnosed with both Myasthenia Gravis (MG) and Amyotrophic Lateral Sclerosis (ALS) was treated with their developed stem cell therapy and has responded positively to this innovative treatment method. The patient showed significant improvements in the ability to speak and walk. The patient is now able to deliver clear sentences and enunciate words in a audible manner,and demonstrates significant cognitive and motor function improvements. The company has demonstrated the molecular and pharmacological methods of their therapy in over 20 scientific publications ; they plan to conduct a phase II clinical trial in the US in 2014.
RSS Feed